Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-06-28 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
EYES | Second Sight Medical | 8.16 | -0.08 | -0.97% | 229.9M |
You can purchase shares of Second Sight Medical (NASDAQ: EYES) through any online brokerage.
Other companies in Second Sight Medical’s space includes: Venus Concept (NASDAQ:VERO), PAVmed (NASDAQ:PAVM) and Soliton (NASDAQ:SOLY).
The latest price target for Second Sight Medical (NASDAQ: EYES) was reported by Dougherty & Co. on 2019-12-13. The analyst firm set a price target for 2.00 expecting EYES to fall to within 12 months (a possible -75.73% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Second Sight Medical (NASDAQ: EYES) is $8.24 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Second Sight Medical.
There is no upcoming split for Second Sight Medical.